These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21454105)
1. Extracorporeal shock wave therapy induces therapeutic lymphangiogenesis in a rat model of secondary lymphoedema. Serizawa F; Ito K; Matsubara M; Sato A; Shimokawa H; Satomi S Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):254-60. PubMed ID: 21454105 [TBL] [Abstract][Full Text] [Related]
2. Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis. Kubo M; Li TS; Kamota T; Ohshima M; Shirasawa B; Hamano K J Vasc Surg; 2010 Aug; 52(2):429-34. PubMed ID: 20670777 [TBL] [Abstract][Full Text] [Related]
3. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis. Kim IG; Lee JY; Lee DS; Kwon JY; Hwang JH J Vasc Res; 2013; 50(2):124-33. PubMed ID: 23208012 [TBL] [Abstract][Full Text] [Related]
4. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986 [TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184 [TBL] [Abstract][Full Text] [Related]
6. [Experimental studies of VEGF-C gene for the treatment of chronic obstructive lymphedema in mouse tail model]. Hu XQ; Jiang ZH; Liu NF Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 May; 24(3):207-11. PubMed ID: 18717357 [TBL] [Abstract][Full Text] [Related]
7. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer. Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197 [TBL] [Abstract][Full Text] [Related]
8. [Experimental study of gene therapy with human vascular endothelial growth factor-c in lymphedema]. Zhou JG; Hu XQ; Cao WG; Li SL; Cheng KX; Liu NF; Zhang DS; Wu JJ; Yin LM; Liu DL Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Nov; 23(6):519-21. PubMed ID: 18269031 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Hwang JH; Kim IG; Lee JY; Piao S; Lee DS; Lee TS; Ra JC; Lee JY Biomaterials; 2011 Jul; 32(19):4415-23. PubMed ID: 21421266 [TBL] [Abstract][Full Text] [Related]
10. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer]. Chen JS; Zhang YJ; Hu SE; Zhang HQ Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855 [TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma. Guo B; Zhang Y; Luo G; Li L; Zhang J Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness of gene therapy with vascular endothelial growth factor or shock wave therapy to reduce ischaemic necrosis in an epigastric skin flap model in rats. Meirer R; Huemer GM; Oehlbauer M; Wanner S; Piza-Katzer H; Kamelger FS J Plast Reconstr Aesthet Surg; 2007; 60(3):266-71. PubMed ID: 17293284 [TBL] [Abstract][Full Text] [Related]
13. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376 [TBL] [Abstract][Full Text] [Related]
14. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer]. Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells. Cheng T; Cao W; Wen R; Steinberg RH; LaVail MM Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):581-91. PubMed ID: 9501870 [TBL] [Abstract][Full Text] [Related]
18. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Ohta Y; Shridhar V; Bright RK; Kalemkerian GP; Du W; Carbone M; Watanabe Y; Pass HI Br J Cancer; 1999 Sep; 81(1):54-61. PubMed ID: 10487612 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837 [TBL] [Abstract][Full Text] [Related]
20. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Aicher A; Heeschen C; Sasaki K; Urbich C; Zeiher AM; Dimmeler S Circulation; 2006 Dec; 114(25):2823-30. PubMed ID: 17145991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]